• Gastrin I: Designing Translational GI Assays

  2026-09-02

  Discover how human Gastrin I peptide can be used as a compartment-aware perturbation tool across gastric signaling and human intestinal organoid workflows. This article translates recent hiPSC-organoid advances into practical assay design, controls, and interpretation strategies.

• Tp47, PKM2, and Inflammatory Senescence

  2026-09-02

  The reference study identifies a mechanistic link between the Treponema pallidum protein Tp47, PKM2-dependent metabolic reprogramming, and inflammatory senescence in macrophages. Its findings suggest that glycolysis, lactate signaling, EIF2AK2 phosphorylation, and NLRP3-associated pyroptosis cooperate to produce a senescence-like inflammatory state relevant to syphilis pathogenesis.

• T-5224 Induces Ferroptosis in Myeloma via PI3K/AKT

  2026-09-01

  The 2024 Heliyon study identifies ferroptosis as a previously underexplored mechanism of T-5224-mediated killing in multiple myeloma cells. By combining ferroptosis rescue experiments with PI3K/AKT pathway analysis, the work provides a mechanistic framework for evaluating AP-1 inhibition alongside bortezomib in preclinical myeloma research.

• PP 2 (AG 1879) for Src Signaling Workflows

  2026-09-01

  PP 2 (AG 1879) provides a practical way to interrogate Lck, Fyn, and broader Src-family signaling in cancer, immune, and vascular experiments. This guide links biochemical selectivity to cell-based workflow design, dose interpretation, and troubleshooting for proliferation, invasion, phosphorylation, and contractility assays.

• ARCA EGFP mRNA (5-moUTP) Workflow Guide

  2026-08-31

  Build a faster, more reproducible fluorescence-based transfection control with a capped, modified, polyadenylated reporter mRNA. This guide connects product handling, mammalian-cell assay design, storage science, and troubleshooting so EGFP signal becomes a quantitative workflow readout rather than a simple yes-or-no endpoint.

• Entamoeba Prx Activates Macrophage Autophagy

  2026-08-31

  The reference study identifies Entamoeba histolytica peroxiredoxin as a parasite-derived stimulus that activates autophagy and cytotoxicity in macrophages. Its central advance is the connection of this response to the TLR4–TRIF pathway and localization of activity to the protein’s C-terminal 100 amino acids, providing a mechanistic link between parasite antioxidant biology and host innate immunity.

• Carfilzomib: A Mechanistic Assay Framework

  2026-08-30

  Carfilzomib and PR-171 provide a powerful model for studying irreversible proteasome inhibition in cancer research. This article goes beyond standard protocols to connect proteostasis failure with ER stress, apoptosis, paraptosis, ferroptosis, and evidence-based assay design.

• Angiotensin Peptides and SARS-CoV-2 Spike Binding

  2026-08-29

  Oliveira and colleagues show that naturally occurring angiotensin fragments can increase SARS-CoV-2 spike-protein binding to host receptors, with the strongest effects observed for selected shorter and N-terminally truncated peptides. The work connects renin–angiotensin signaling with viral-entry biochemistry while emphasizing that receptor-binding assays do not by themselves establish clinical effects or infection enhancement in vivo.

• Sildenafil Citrate: PDE5 Research Guide

  2026-08-28

  Sildenafil Citrate is a cGMP-specific phosphodiesterase type 5 inhibitor for mechanistic vascular research. Its reported PDE5 potency, solubility profile, ERK1/ERK2 phosphorylation modulation, and proteoform-relevant PDE6 off-target findings support carefully controlled studies rather than unqualified extrapolation to every vascular model.

• hAESC-Derived Dopaminergic Cells in Parkinson’s Rats

  2026-08-28

  The 2024 Life Sciences study developed dopaminergic neuron-like cells from human amniotic epithelial stem cells and evaluated them in a rat model of Parkinson’s disease. The cells showed dopaminergic features, dopamine secretion, low tumorigenicity, and low immunogenicity, while transplantation improved motor behavior and TH-positive neuronal reinnervation.

• NADH Reductive Stress in Leigh Syndrome

  2026-08-27

  This pilot study uses streamlined LC-MS/MS to quantify NADH and NAD+ in patient-derived fibroblasts and an Ndufs4-knockout mouse model of Leigh syndrome. Its central finding is that elevated NADH, rather than reduced NAD+, is associated with reductive stress, supporting NADH as a potentially more direct biomarker of mitochondrial disease severity than lactate alone.

• Rocket-Like Nanomedicine Restores PDAC Stromal Homeostasis

  2026-08-27

  A 2026 Materials Today Bio study developed an acid-responsive, sequential-release nanomedicine that combines halofuginone and IPR-803 with gemcitabine to remodel pancreatic tumor stroma before chemotherapy delivery. The approach produced marked tumor regression in a pancreatic ductal adenocarcinoma mouse model and illustrates how competitive uPAR inhibition can be integrated into stroma-directed drug delivery.

• Protease Inhibitor Cocktail for Metabolic Signaling

  2026-08-26

  Discover how a Protease Inhibitor Cocktail EDTA-Free can protect signaling proteins during metabolic disease research. This guide connects pre-analytical sample control with the AMPK–PGC1α findings of a recent dAGE mouse study.

• Dabigatran for Thromboembolic Disease: Evidence Review

  2026-08-26

  This 2015 review examines dabigatran as the first widely introduced non-vitamin K oral anticoagulant, integrating pharmacology, randomized trial evidence, safety data, and practical management considerations. Its main contribution is a clinically oriented framework showing how predictable exposure, fixed dosing, and reduced intracranial hemorrhage can simplify prevention and treatment of thromboembolic disease while making renal function and bleeding management central to patient selection.

• Amplex Red for Reliable Cell Redox Assays

  2026-08-25

  Learn how Amplex Red (SKU C4839) supports sensitive hydrogen peroxide and peroxidase measurements while avoiding common cell-assay artifacts. This scenario-driven guide covers assay design, compatibility controls, protocol parameters, interpretation, and practical product selection for biomedical laboratories.

8376 records 2/559 page Previous Next 12345 下5页 Last page